Last reviewed · How we verify

NCT06957873

Craniovertebral Angle and Fibromyalgia Severity

Recruiting now Last updated 17 April 2026
What this trial tests

trial in Craniovertebral Angle in 134 participants. Currently enrolling.

Timeline
1 April 2025
Primary endpoint
1 August 2026
1 August 2026

Quick facts

Lead sponsorAnkara Training and Research Hospital
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment134
Start date1 April 2025
Primary completion1 August 2026
Estimated completion1 August 2026
Sites3 locations across Turkey (Türkiye)

Conditions studied

Sponsor

Ankara Training and Research Hospital

Who can join

Adults 18 to 55, any sex, with Craniovertebral Angle or Fibromyalgia Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Forward Head Posture Frequency in Fibromyalgia Patients Assessed by Craniovertebral Angle: Association with Symptom Severity. Forward head posture is more common in patients with fibromyalgia and is a factor that increases symptom severity.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Craniovertebral Angle

Currently open trials in the same condition.

Other Ankara Training and Research Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06957873.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing